US FDA approved drugs from 2015–June 2020: a perspective

P Bhutani, G Joshi, N Raja, N Bachhav… - Journal of Medicinal …, 2021 - ACS Publications
In the present work, we report compilation and analysis of 245 drugs, including small and
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …

US FDA Approved Drugs from 2015-June 2020: A Perspective

P Bhutani, G Joshi, N Raja, N Bachhav, PK Rajanna… - 2021 - kr.cup.edu.in
In the present work, we report compilation and analysis of 245 drugs, including small and
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …

[引用][C] US FDA Approved Drugs from 2015–June 2020: A Perspective

P Bhutani, G Joshi, N Raja, N Bachhav… - Journal of Medicinal …, 2021 - cir.nii.ac.jp
US FDA Approved Drugs from 2015–June 2020: A Perspective | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

US FDA Approved Drugs from 2015-June 2020: A Perspective.

P Bhutani, G Joshi, N Raja, N Bachhav… - Journal of Medicinal …, 2021 - europepmc.org
In the present work, we report compilation and analysis of 245 drugs, including small and
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …

US FDA Approved Drugs from 2015-June 2020: A Perspective

P Bhutani, G Joshi, N Raja… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
In the present work, we report compilation and analysis of 245 drugs, including small and
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …

US FDA Approved Drugs from 2015-June 2020: A Perspective

P Bhutani, G Joshi, N Raja, N Bachhav, PK Rajanna… - 2021 - 14.139.242.3
In the present work, we report compilation and analysis of 245 drugs, including small and
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …